IL299756A - Isoquinoline compounds and their use in the treatment of AHR imbalance - Google Patents
Isoquinoline compounds and their use in the treatment of AHR imbalanceInfo
- Publication number
- IL299756A IL299756A IL299756A IL29975623A IL299756A IL 299756 A IL299756 A IL 299756A IL 299756 A IL299756 A IL 299756A IL 29975623 A IL29975623 A IL 29975623A IL 299756 A IL299756 A IL 299756A
- Authority
- IL
- Israel
- Prior art keywords
- optionally substituted
- alkyl
- compound
- group
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063052574P | 2020-07-16 | 2020-07-16 | |
| US202063052561P | 2020-07-16 | 2020-07-16 | |
| PCT/US2021/034599 WO2022015423A1 (en) | 2020-07-16 | 2021-05-27 | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299756A true IL299756A (en) | 2023-03-01 |
Family
ID=79293345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299756A IL299756A (en) | 2020-07-16 | 2021-05-27 | Isoquinoline compounds and their use in the treatment of AHR imbalance |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US11267788B2 (https=) |
| EP (1) | EP4185566A4 (https=) |
| JP (1) | JP2023533855A (https=) |
| KR (1) | KR20230041021A (https=) |
| CN (1) | CN116157387A (https=) |
| AU (1) | AU2021308209A1 (https=) |
| CA (1) | CA3185793A1 (https=) |
| IL (1) | IL299756A (https=) |
| MX (1) | MX2023000263A (https=) |
| WO (1) | WO2022015423A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023533855A (ja) | 2020-07-16 | 2023-08-04 | ダーマヴァント サイエンシーズ ゲーエムベーハー | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 |
| WO2024020170A1 (en) * | 2022-07-21 | 2024-01-25 | Allianthera (Suzhou) Biopharmaceutical Co., Ltd. | Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof |
| US20260069585A1 (en) * | 2022-08-30 | 2026-03-12 | Dermavant Sciences GmbH | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES |
| WO2024152993A1 (zh) * | 2023-01-17 | 2024-07-25 | 上海泽德曼医药科技有限公司 | 稠环类化合物、其制备方法及其在医药上的应用 |
| CN117447402A (zh) * | 2023-10-18 | 2024-01-26 | 德明药泰生物技术（深圳）有限公司 | 芳香烃受体调节剂类化合物及其制备方法和应用 |
| CN117229208B (zh) * | 2023-11-13 | 2024-02-23 | 上海泽德曼医药科技有限公司 | 稠环类化合物、其制备方法及其在医药上的应用 |
| WO2026083733A1 (ja) * | 2024-10-18 | 2026-04-23 | 株式会社ヤクルト本社 | 試験方法、ゲル状組成物、及び試験装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992018123A2 (en) | 1991-04-10 | 1992-10-29 | Octamer, Inc. | A method for inhibition of retroviral replication |
| US5919970A (en) | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
| ATE404539T1 (de) * | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
| HRP20040102A2 (en) | 2001-07-09 | 2004-10-31 | Combinatorx | Combinations for the treatment of inflammatory disorders |
| WO2003053359A2 (en) * | 2001-12-19 | 2003-07-03 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| IL162533A0 (en) * | 2001-12-19 | 2005-11-20 | Atherogenics Inc | Chalcone derivatives and their use to treat diseases |
| JPWO2005063222A1 (ja) | 2003-12-26 | 2007-07-19 | 協和醗酵工業株式会社 | Ｈｓｐ９０ファミリー蛋白質阻害剤 |
| WO2006058201A2 (en) | 2004-11-23 | 2006-06-01 | Reddy Us Therapeutics, Inc. | Heterocyclic and bicyclic compounds, compositions and methods |
| GB0704718D0 (en) | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| EP2014651A1 (en) | 2007-07-12 | 2009-01-14 | Exonhit Therapeutics SA | Compounds and methods for modulating Rho GTPases |
| JP5439127B2 (ja) | 2009-11-13 | 2014-03-12 | 株式会社さいわいメディカル | 乾癬又はアトピー性皮膚炎治療剤 |
| WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| GB201216017D0 (en) * | 2012-09-07 | 2012-10-24 | Cancer Rec Tech Ltd | Inhibitor compounds |
| AU2013361314A1 (en) | 2012-12-20 | 2015-07-02 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
| GB201304041D0 (en) | 2013-03-06 | 2013-04-17 | Water Jel Europ Llp | Treatment and prophylaxis of radiation dermatitis |
| US10626094B2 (en) | 2014-10-14 | 2020-04-21 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof |
| JP7138654B2 (ja) * | 2017-03-29 | 2022-09-16 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 金属錯体 |
| US11548867B2 (en) * | 2017-07-19 | 2023-01-10 | Idea Ya Biosciences, Inc. | Amido compounds as AhR modulators |
| EP3752512B1 (de) * | 2018-02-13 | 2023-03-01 | Merck Patent GmbH | Metallkomplexe |
| TWI828664B (zh) | 2018-03-19 | 2024-01-11 | 愛爾蘭商Ｕｄｃ愛爾蘭責任有限公司 | 金屬錯合物 |
| JP2023533855A (ja) | 2020-07-16 | 2023-08-04 | ダーマヴァント サイエンシーズ ゲーエムベーハー | イソキノリン化合物およびそのＡｈＲ不均衡の治療への使用 |
| WO2023020512A1 (zh) * | 2021-08-16 | 2023-02-23 | 成都奥睿药业有限公司 | 取代的吡啶类似物、其制备方法及作为ahr调节剂的用途 |
| CN116947799B (zh) * | 2023-03-08 | 2024-05-03 | 上海泽德曼医药科技有限公司 | 酚类化合物、其制备方法及其在医药上的应用 |
-
2021
- 2021-05-27 JP JP2023502881A patent/JP2023533855A/ja active Pending
- 2021-05-27 KR KR1020237005000A patent/KR20230041021A/ko active Pending
- 2021-05-27 IL IL299756A patent/IL299756A/en unknown
- 2021-05-27 EP EP21842240.0A patent/EP4185566A4/en active Pending
- 2021-05-27 CA CA3185793A patent/CA3185793A1/en active Pending
- 2021-05-27 AU AU2021308209A patent/AU2021308209A1/en active Pending
- 2021-05-27 US US17/332,805 patent/US11267788B2/en active Active
- 2021-05-27 CN CN202180060054.5A patent/CN116157387A/zh active Pending
- 2021-05-27 WO PCT/US2021/034599 patent/WO2022015423A1/en not_active Ceased
- 2021-05-27 MX MX2023000263A patent/MX2023000263A/es unknown
-
2022
- 2022-01-28 US US17/587,812 patent/US11548853B2/en active Active
- 2022-10-28 US US18/050,888 patent/US11827605B2/en active Active
-
2023
- 2023-10-20 US US18/491,538 patent/US12252471B2/en active Active
-
2025
- 2025-02-14 US US19/053,643 patent/US20250282730A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240208910A1 (en) | 2024-06-27 |
| EP4185566A4 (en) | 2024-12-04 |
| KR20230041021A (ko) | 2023-03-23 |
| US20250282730A1 (en) | 2025-09-11 |
| MX2023000263A (es) | 2023-03-29 |
| US11827605B2 (en) | 2023-11-28 |
| AU2021308209A8 (en) | 2023-04-13 |
| CN116157387A (zh) | 2023-05-23 |
| AU2021308209A1 (en) | 2023-02-09 |
| US12252471B2 (en) | 2025-03-18 |
| CA3185793A1 (en) | 2022-01-20 |
| JP2023533855A (ja) | 2023-08-04 |
| WO2022015423A1 (en) | 2022-01-20 |
| US20220153703A1 (en) | 2022-05-19 |
| US11267788B2 (en) | 2022-03-08 |
| US11548853B2 (en) | 2023-01-10 |
| EP4185566A1 (en) | 2023-05-31 |
| US20230124135A1 (en) | 2023-04-20 |
| US20220017468A1 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12252471B2 (en) | Isoquinoline compounds and their use in treating AhR imbalance | |
| US11535606B2 (en) | Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof | |
| EP2125803B1 (fr) | Composes pyrrolo[2,3-b]pyridine, composes azaindoles utiles dans la synthese de ces composes pyrrolo[2,3-b]pyridine, leurs procedes de fabrication et leurs utilisations | |
| CN102408429A (zh) | 抑制醛甾酮合酶和芳香酶的稠合咪唑并衍生物 | |
| WO2017129116A1 (zh) | 吡咯嘧啶五元氮杂环衍生物及其应用 | |
| US20240216361A1 (en) | Ror-gamma modulators | |
| JP2022529311A (ja) | Ｔｙｋ２偽キナーゼリガンド | |
| NO325401B1 (no) | Laktamforbindelser, anvendelse av slike samt farmasoytisk preparat inneholdende nevnte laktamforbindelser | |
| US20250326720A1 (en) | Carebastine salt and use of same | |
| US20160102058A1 (en) | Fluoro-perhexiline compounds and their therapeutic use | |
| EP4183785A1 (en) | Novel n-heterocyclic bet bromodomain inhibitor, and preparation method therefor and medical use thereof | |
| CN101479246A (zh) | 氨基-乙基-氨基-芳基(aeaa)化合物和它们的用途 | |
| WO2004082683A1 (ja) | 慢性皮膚疾患の治療および／または予防剤 | |
| HK40080028B (zh) | Tyk2假激酶配体 | |
| GB2560769A (en) | Compounds and compositions for use in treating psoriasis | |
| JPH08268949A (ja) | ジフェニルメチレン誘導体 | |
| HK40066192A (zh) | Tyk2假激酶配体 | |
| HK40066192B (zh) | Tyk2假激酶配体 |